Howe D T, Gornall R, Wellesley D, Boyle T, Barber J
Wessex Maternal and Fetal Medicine Unit, Princess Anne Hospital, Southampton SO16 5YA.
BMJ. 2000 Mar 4;320(7235):606-10. doi: 10.1136/bmj.320.7235.606.
To assess the effectiveness of antenatal screening for Down's syndrome by maternal age and routine mid-pregnancy ultrasound scanning.
Retrospective six year survey.
Maternity units of a district general hospital.
Pregnant women booked for delivery in hospital between 1 January 1993 and 31 December 1998.
All cases of Down's syndrome occurring in district identified from regional congenital anomaly register and cytogenetic laboratory records. Women's case notes were examined to identify indication for karyotyping, gestation at diagnosis, and outcome of pregnancy.
31 259 deliveries occurred during study period, and 57 cases of Down's syndrome were identified, four in failed pregnancies and 53 in ongoing pregnancies or in neonates. The analysis was confined to ongoing pregnancies or liveborn children. Invasive antenatal tests were performed in 6.6% (2053/31 259), and 68% (95% confidence interval 56% to 80%) of cases of Down's syndrome were detected antenatally, giving a positive predictive value of 1.8%. There were 17 undetected cases, and in seven of these the women had declined an offer of invasive testing. In women aged less than 35 years the detection rate was 53% (30% to 76%). Most of the cases detected in younger women followed identification of ultrasound anomalies.
The overall detection rate was considerably higher than assumed in demonstration projects for serum screening. As a result, the benefits of serum screening are much less than supposed. Before any new methods to identify Down's syndrome are introduced, such as nuchal translucency or first trimester serum screening, the techniques should be tested in properly controlled trials.
通过孕妇年龄和常规孕中期超声扫描评估唐氏综合征产前筛查的有效性。
回顾性六年调查。
一家地区综合医院的产科病房。
1993年1月1日至1998年12月31日期间在医院预约分娩的孕妇。
从地区先天性异常登记册和细胞遗传学实验室记录中识别出的该地区所有唐氏综合征病例。检查产妇病历以确定核型分析的指征、诊断时的孕周和妊娠结局。
研究期间共分娩31259例,确诊57例唐氏综合征,4例为妊娠失败,53例为持续妊娠或新生儿。分析仅限于持续妊娠或活产儿。6.6%(2053/31259)的孕妇接受了侵入性产前检查,68%(95%置信区间56%至80%)的唐氏综合征病例在产前被检测出,阳性预测值为1.8%。有17例未被检测出,其中7例孕妇拒绝了侵入性检查。年龄小于35岁的孕妇中,检测率为53%(30%至76%)。年轻女性中检测出的大多数病例是在超声发现异常后确诊的。
总体检测率远高于血清筛查示范项目中的假设。因此,血清筛查的益处远低于预期。在引入任何新的唐氏综合征识别方法(如颈部透明带或孕早期血清筛查)之前,应在适当控制的试验中对这些技术进行测试。